University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Benjamin Kim, MD

Benjamin Kim, MD

Assistant Professor of Clinical Medicine

Cancer Center Program Memberships

Cancer Control

Education

Northwestern University; Evanston, IL, B.A., 09/96-06/99, Sociology
Feinberg School of Medicine, Northwestern University; Chicago, IL, M.D., 08/99-05/03
Medicine, McGaw Medical Center, Northwestern Memorial Hospital; Chicago, IL, 06/03-06/06, Residency, Internal Medicine
Ronald Reagan UCLA Medical Center; Los Angeles, CA, 07/06-09/11
Fellowship, Hematology-Oncology, Pardee RAND Graduate School; Santa Monica, CA, M.Phil., 09/07-09/11, Policy Analysis, Ph.D. expected 2012
 


Professional Experience

  • 2003-2006
    Internal Medicine Residency, Northwestern Memorial Hospital; Chicago, IL
  • 2006-2009
    Clinical Hematology-Oncology Fellowship, UCLA Medical Center; Los Angeles, CA
  • 2007-2011
    Graduate Student, Pardee RAND Graduate School; Santa Monica, CA
  • 2009-2011
    Postdoctoral Hematology-Oncology Fellowship, UCLA Medical Center; Los Angeles, CA
  • 2011-
    Adjunct Staff Researcher, RAND; Santa Monica, CA
  • 2011-
    Assistant Professor of Clinical Medicine, UCSF School of Medicine; San Francisco, CA

Honors & Awards

  • 2000
    John A. Hartford/AFAR Medical Student Scholarship, American Federation of Aging Research

  • 2003, 2004, 2006
    Goldberg Family Charitable Trust Travel Award, Northwestern Memorial Foundation

  • 2004, 2005
    Excellence in Teaching Award, Department of Medicine, Northwestern University

  • 2006
    James R. Webster, Jr. Award, Department of Medicine, Northwestern University

  • 2006
    ATVB Merit Award for Young Investigators, American Heart Association

  • 2006-2011
    Specialty Training & Advanced Research Program, UCLA School of Medicine

  • 2008-2009
    Chief Fellow, Division of Hematology-Oncology, UCLA School of Medicine

  • 2008-2010
    NIH Loan Repayment Program, NHLBI

  • 2012
    Mount Zion Health Fund Educational Travel Award

  • 2012
    Hematology Teaching Award, Department of Medicine, UCSF

Selected Publications

  1. Oldenburg J, Mahlangu JN, Kim B, Schmitt C, Callaghan MU, Young G, Santagostino E, Kruse-Jarres R, Negrier C, Kessler C, Valente N, Asikanius E, Levy GG, Windyga J, Shima M. Emicizumab Prophylaxis in Hemophilia A with Inhibitors. N Engl J Med. 2017 08 31; 377(9):809-818.
    View on PubMed
  2. Gray SW, Kim B, Sholl L, Cronin A, Parikh AR, Klabunde CN, Kahn KL, Haggstrom DA, Keating NL. Medical Oncologists' Experiences in Using Genomic Testing for Lung and Colorectal Cancer Care. J Oncol Pract. 2017 Mar; 13(3):e185-e196.
    View on PubMed
  3. Rendon P, Dhaliwal G, Kim B, Aguayo A, Pierce JR. Look No Further: An Exercise in Clinical Reasoning. J Gen Intern Med. 2016 Sep; 31(9):1097-101.
    View on PubMed
  4. Parikh AR, Keating NL, Liu PH, Gray SW, Klabunde CN, Kahn KL, Haggstrom DA, Syngal S, Kim B. Oncologists' Selection of Genetic and Molecular Testing in the Evolving Landscape of Stage II Colorectal Cancer. J Oncol Pract. 2016 Mar; 12(3):e308-19, 259-60.
    View on PubMed
  5. Zhu JM, Hamel D, Dhaliwal G, Glass M, Sharpe B, Kim B, Monash B. Breakdown. J Hosp Med. 2016 Feb; 11(2):126-9.
    View on PubMed
  6. Delate T, Hsiao W, Kim B, Witt DM, Meyer MR, Go AS, Fang MC. Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism. Thromb Res. 2016 Jan; 137:97-102.
    View on PubMed
  7. Ahluwalia SC, Tisnado DM, Walling AM, Dy SM, Asch SM, Ettner SL, Kim B, Pantoja P, Schreibeis-Baum HC, Lorenz KA. Association of Early Patient-Physician Care Planning Discussions and End-of-Life Care Intensity in Advanced Cancer. J Palliat Med. 2015 Oct; 18(10):834-41.
    View on PubMed
  8. Gidengil CA, Predmore Z, Mattke S, van Busum K, Kim B. Breast implant-associated anaplastic large cell lymphoma: a systematic review. Plast Reconstr Surg. 2015 Mar; 135(3):713-20.
    View on PubMed
  9. Kim B, Predmore ZS, Mattke S, van Busum K, Gidengil CA. Breast Implant-associated Anaplastic Large Cell Lymphoma: Updated Results from a Structured Expert Consultation Process. Plast Reconstr Surg Glob Open. 2015 Jan; 3(1):e296.
    View on PubMed
  10. Olson AP, Sahni N, Kim B, Dhaliwal G. Not a textbook case. J Hosp Med. 2015 Apr; 10(4):266-70.
    View on PubMed
  11. Kehl KL, Gray SW, Kim B, Kahn KL, Haggstrom D, Roudier M, Keating NL. Oncologists' experiences with drug shortages. J Oncol Pract. 2015 Mar; 11(2):e154-62.
    View on PubMed
  12. Kim B, Garcia DA. What is the role of hemodialysis for dabigatran-associated major bleeding? Hematology Am Soc Hematol Educ Program. 2014 Dec 05; 2014(1):514-7.
    View on PubMed
  13. Oishi SM, Antonio AL, Ryoo J, Ordin DL, Lorenz KA, He R, Asch SM, Kim B, Malin J. Quality of supportive care for patients with advanced lung cancer in the Veterans Health Administration. J Community Support Oncol. 2014 Oct; 12(10):361-9.
    View on PubMed
  14. Ryoo JJ, Malin JL, Ordin DL, Oishi SM, Kim B, Asch SM, He R, Gould MK. Facility characteristics and quality of lung cancer care in an integrated health care system. J Thorac Oncol. 2014 Apr; 9(4):447-55.
    View on PubMed
  15. Kim B, Hing ZA, Wu A, Schiller T, Struble EB, Liuwantara D, Kempert PH, Broxham EJ, Edwards NC, Marder VJ, Simhadri VL, Sauna ZE, Howard TE, Kimchi-Sarfaty C. Single-nucleotide variations defining previously unreported ADAMTS13 haplotypes are associated with differential expression and activity of the VWF-cleaving protease in a Salvadoran congenital thrombotic thrombocytopenic purpura family. Br J Haematol. 2014 Apr; 165(1):154-8.
    View on PubMed
  16. Houchens N, Dhaliwal G, Askari F, Kim B, Saint S. Clinical problem-solving. The essential element. N Engl J Med. 2013 Apr 04; 368(14):1345-51.
    View on PubMed
  17. Kim B, Schroeder BE, Schnabel CA, Erlander MG, Malin JL. Physician-reported clinical utility of the 92-gene molecular classifier in tumors with uncertain diagnosis following standard clinicopathologic evaluation. Pers Med Oncol. 2013; 2(2):68-76.
    View on PubMed
  18. Jacquot C, Moayeri M, Kim B, Shugarts S, Lynch KL, Leavitt AD. Prolonged ceftriaxone-induced immune thrombocytopenia due to impaired drug clearance: a case report. Transfusion. 2013 Nov; 53(11):2715-21.
    View on PubMed
  19. Sauna ZE, Ameri A, Kim B, Yanover C, Viel KR, Rajalingam R, Cole SA, Howard TE. Observations regarding the immunogenicity of BDD-rFVIII derived from a mechanistic personalized medicine perspective. J Thromb Haemost. 2012 Sep; 10(9):1961-5.
    View on PubMed
  20. Young P, Kim B, Malin JL. Preoperative breast MRI in early-stage breast cancer. Breast Cancer Res Treat. 2012 Oct; 135(3):907-12.
    View on PubMed

Go to UCSF Profiles, powered by CTSI